Prognostic Utility of Perivascular Adipose Tissue Attenuation in Patients Undergoing Endovascular Aneurysm Repair for Abdominal Aortic Aneurysms

View at publisher
Authors: Koshi Matsuhama, Takayoshi Toba, Yoichiro Sugizaki, Tatsuya Kitagawa, Shotaro Yoshida, Mayuka Masuda, Keisuke Iida, Ken Takata, Nobuhiro Watanabe, Koutaro Higuchi, Hiroya Okamoto, Yuta Fukuishi
+18 more Yuki Sakamoto, Shota Naniwa, Hiroshi Tsunamoto, Tetsuya Yamamoto, Seigo Iwane, Yuto Osumi, Daichi Fujimoto, Takashi Hiromasa, Hiroyuki Kawamori, Hironaga Shiraki, Taishi Inoue, Katsuhiro Yamanaka, Hiroaki Takahashi, Tomoyuki Gentsu, Koji Sasaki, Masato Yamaguchi, Kenji Okada, Hiromasa Otake
Cited by: 1
References: 26

Abstract

BACKGROUND: Perivascular adipose tissue (PVAT) attenuation on computed tomography angiography reflects vascular inflammation. However, its prognostic value in patients undergoing endovascular aortic repair (EVAR) for abdominal aortic aneurysm (AAA) remains unclear. METHODS: We retrospectively studied consecutive patients who underwent EVAR for unruptured infrarenal AAA with preprocedural computed tomography angiography. PVAT attenuation and aortic characteristics were assessed using computed tomography angiography. The primary outcome was major adverse cardiac or cerebrovascular events (MACCE), a composite of all-cause death, myocardial infarction, stroke, and any vessel treatment. RESULTS: Among 275 patients treated with EVAR, 35.6% (98/275) experienced MACCE during a median follow-up of 3.5 years. Pre-EVAR PVAT attenuation was higher in patients who experienced MACCE than in those who did not (−69.8±10.3 HU versus −77.3±8.6 HU; P

Fields of Study & Subjects

Cardiovascular Disease and Adiposity Aortic aneurysm repair treatments Peripheral Artery Disease Management

Publication details

Journal / source
Circulation Cardiovascular Imaging
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
19
Issue
5
Pages
e019185–e019185
Publication date
28 April 2026
Language
EN